Buscar
01/08/2024
IDENTIFICATION OF NEW THERAPEUTIC TARGETS AND BIOMARKERS IN PATIENTS WITH ASCENDING AORTIC ANEURYSM ACCORDING WITH THEIR GENETIC HETEROGENEITY
Galán, M, Almendra-Pegueros, R, Barros, AJ, Tabilo, JF, Dominguez-Tenreiro, M, Fernández, LM, Pérez-Marlasca, E, Borrás, N, Vidal, F, Martinez-González, J, Rodríguez, C. IDENTIFICATION OF NEW THERAPEUTIC TARGETS AND BIOMARKERS IN PATIENTS WITH ASCENDING AORTIC ANEURYSM ACCORDING WITH THEIR GENETIC HETEROGENEITY. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT
Velasco, L, Querol, CB, Santos, D, Rotllan, N, Tondo, M, Camacho, M, Blanco-Vaca, F, Escolà-Gil, JC, Canyelles, M. IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS
Grao-Cruces, E, Mocciaro, G, Marquez-Paradas, E, Santos-Mejias, A, Canyelles, M, Escola-Gil, JC, Martin-Rubio, ME, La Paz, SMD. HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study
Vlacho, B, Iniesta, AM, Gratacòs, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Cos, FX, Franch-Nadal, J, Mauricio, D. Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study. Primary Care Diabetes. 2024; 18(4)DOI:10.1016/j.pcd.2024.05.001. PMID:38782704. IF:2.300(Q2/5D).
01/08/2024
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial
Orna, JAG, Martínez, ABM, Padial, LR, Sánchez, MA, Barrios, V, García, JM, Perez, AP. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial. Endocrinologia Diabetes y Nutricion. 2024; 71(7)DOI:10.1016/j.endien.2024.07.001. PMID:39095283. IF:1.800(Q3/8D).
01/08/2024
Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders
Liu, JM, Xie, XL, García-Patterson, A, Asla, Q, Sardà, H, Chico, A, Adelantado, JM, Urgell, E, Corcoy, R. Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2024; 310(2)DOI:10.1007/s00404-023-07279-z. PMID:37981602. IF:2.500(Q2/3D).
01/08/2024
Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease
Brujats, A, Huerta, A, Osuna-Gómez, R, Guinart-Cuadra, A, Ferrero-Gregori, A, Pujol, C, Soriano, G, Poca, M, Fajardo, J, Escorsell, A, Gallego, A, Vidal, S, Villanueva, C, Alvarado-Tapias, E. Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158302. PMID:39125872. IF:4.900(Q1/3D).
01/08/2024
Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation
Alonso-Tarrés, C, Moreno, CB, Navarro, F, Habison, AC, Gonzàlez-Bertran, E, Blanco, F, Borràs, J, Garrigó, M, Saker, J. Bacteriuria and phenotypic antimicrobial susceptibility testing in 45 min by point-of-care Sysmex PA-100 System: first clinical evaluation. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2024; 43(8)DOI:10.1007/s10096-024-04862-3. PMID:38825624. IF:3.000(Q2/4D).